Send to

Choose Destination
Oncotarget. 2017 Nov 27;8(64):107346-107347. doi: 10.18632/oncotarget.22715. eCollection 2017 Dec 8.

Targeting PRC2: RNA offers new opportunities.

Author information

Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia; Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia; EMBL-Australia and the ARC Centre of Excellence in Advanced Molecular Imaging, Clayton, Australia.


G-quadruplex; PRC2; RNA; anticancer therapeutics; polycomb repressive complex 2

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center